Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyUpper Ohio Valley Short-Term CGM Coverage | OpenPa…
    Ask Trek AI about this page
    CurrentHealth Plan of the Upper Ohio ValleyPolicy 13820830

    Short-Term Continuous Glucose Monitors

    Customize your policy alerts

    Sign up for healthplanofupperohiovalley Policy 13820830 alerts

    Get alerted when Policy 13820830 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical-necessity review and coverage of short-term continuous glucose monitoring services lasting 72 hours to one week across all lines of business.

    Policy Summary
    PayerHealth Plan of the Upper Ohio Valley
    PolicyShort-Term Continuous Glucose Monitors
    Policy CodePolicy 13820830
    Change TypeMaterial revision
    Effective DateJul 24, 2023
    Last ReviewMay 24, 2023
    Next Review DateJun 12, 2024
    Key ActionSubmit every short-term continuous glucose monitoring request for medical necessity review.
    SourceLink
    POLICY UPDATE CHANGES

    Criteria were added for pregnant individuals who require insulin therapy or have gestational diabetes.

    The diabetes criterion was revised to specify type I and type II diabetes, and the hypoglycemia criterion was revised to address repeated daily episodes of hypoglycemia and hyperglycemia.

    A diagnosis code subsection and updated references were added during policy revisions.

    72h–1 weekService duration
    5Review requirements
    <50/>150Glucose thresholds

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3CPT codes
    3ICD-10 groups

    Medical Necessity Criteria

    Initial medical-necessity criteria

    Requests for short-term (72 hours to one week) continuous glucose monitoring device services may be considered medically necessary when ANY of the following criteria are met:

    Qualifying indications

    • Type I or type II diabetes with qualifying glucose abnormalities

      • Diabetes-related abnormality: Hypoglycemic unawareness OR repeated daily episodes of hypoglycemia and hyperglycemia.
    • Pregnancy-related indication: The individual is pregnant and requires insulin therapy OR has gestational diabetes.
    • Recurrent hypoglycemia with specified disorder

      • Specified underlying disorder: Primary islet cell hypertrophy (nesidioblastosis) OR persistent hyperinsulinemic hypoglycemia of infancy (PHHI, or congenital hypoglycemia).

    Short-term continuous glucose monitoring device requests that are not addressed by this policy are considered experimental or investigational and are non-covered because safety and efficacy have not been established.

    Codes and Service Parameters

    Procedure CodesCPT
    95249Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; patient-provided equipment, sensor placement, hook-up, calibration of monitor, patient training and printout of recording.
    95250Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; sensor placement, hook-up, calibration of monitor, patient training, removal of sensor, and printout of recording.
    95251Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report.
    Diagnosis CodesICD-10
    E08.00-E13.9Diabetes mellitus.
    O24.011-O24.93Diabetes mellitus in pregnancy, childbirth, and the puerperium.
    P70.2Neonatal diabetes mellitus.
    Short-Term Monitoring Duration
    Covered monitoring duration72 hours to one week
    Hypoglycemia Threshold
    Hypoglycemia threshold<50 mg/dL
    Hyperglycemia Threshold
    Hyperglycemia threshold>150 mg/dL

    Review and Documentation Requirements

    Prior Authorization

    Medical Necessity Review Required

    Every request for a short-term continuous glucose monitoring device lasting 72 hours to one week requires medical necessity review before coverage determination.

    Denial Risk

    Unaddressed Indications Are Non-Covered

    Requests for short-term continuous glucose monitoring devices that are not addressed by this policy are considered experimental or investigational and are non-covered because safety and efficacy have not been established.

    Documentation Required

    Document Medical Necessity

    Policy Background

    Short-term continuous glucose monitors measure and record glucose levels in interstitial fluid and provide data showing glucose trends. This policy addresses short-term monitoring lasting 72 hours to one week for selected diagnostic and glucose-management needs, including diabetes-related glucose abnormalities, insulin-treated pregnancy or gestational diabetes, and recurrent hypoglycemia associated with specified congenital or islet-cell disorders.

    Key Definitions

    Definition
    Short-term continuous glucose monitorA device that monitors, measures, and records glucose levels in interstitial fluid and produces data showing trends in glucose measurement; under this policy, short-term use means 72 hours to one week.
    Definition
    PHHIPersistent hyperinsulinemic hypoglycemia of infancy, also called congenital hypoglycemia.
    Policy Summary
    PayerHealth Plan of the Upper Ohio Valley
    PolicyShort-Term Continuous Glucose Monitors
    Policy CodePolicy 13820830
    Change TypeMaterial revision
    Effective DateJul 24, 2023
    Last ReviewMay 24, 2023
    Next Review DateJun 12, 2024
    Key ActionSubmit every short-term continuous glucose monitoring request for medical necessity review.
    SourceLink
    On This Page
    Medical Necessity CriteriaCodes and Service ParametersReview and Documentation RequirementsPolicy BackgroundKey Definitions

    The medical record must document the applicable medical-necessity criteria supporting the request. This documentation is subject to post-payment audit by THP at any time under the terms of the provider agreement.